Onconetix, Inc.
ONCO
$0.0761
-$0.0039-4.88%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 406.90K | 704.80K | 700.40K | 58.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 406.90K | 704.80K | 700.40K | 58.50K | -- |
| Cost of Revenue | 301.40K | 604.10K | 511.40K | 1.19M | -- |
| Gross Profit | 105.40K | 100.70K | 189.00K | -1.13M | -- |
| SG&A Expenses | 2.64M | 2.22M | 3.74M | 4.47M | 4.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.05M | 2.82M | 4.30M | 5.45M | 4.49M |
| Operating Income | -2.65M | -2.12M | -3.60M | -5.39M | -4.49M |
| Income Before Tax | -3.88M | -14.26M | -11.24M | -22.36M | -5.35M |
| Income Tax Expenses | -56.40K | 50.80K | -121.60K | -12.60K | -- |
| Earnings from Continuing Operations | -3.83M | -14.31M | -11.12M | -22.35M | -5.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.83M | -14.31M | -11.12M | -22.35M | -5.35M |
| EBIT | -2.65M | -2.12M | -3.60M | -5.39M | -4.49M |
| EBITDA | -2.44M | -1.92M | -3.39M | -5.36M | -4.49M |
| EPS Basic | -2.93 | -25.78 | -20.08 | -46.83 | -12.21 |
| Normalized Basic EPS | -1.41 | -2.83 | -4.49 | -2.72 | -6.93 |
| EPS Diluted | -2.93 | -25.78 | -20.08 | -46.83 | -12.21 |
| Normalized Diluted EPS | -1.41 | -2.83 | -4.49 | -2.72 | -6.93 |
| Average Basic Shares Outstanding | 1.31M | 554.90K | 553.70K | 477.20K | 438.00K |
| Average Diluted Shares Outstanding | 1.31M | 554.90K | 553.70K | 477.20K | 438.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |